Effects of SGLT2 inhibitor (Suglat) on insulin sensitivity in patients with type 2 diabetes mellitus by the glucose clamp technique and the meal tolerance test.
Phase of Trial: Phase II
Latest Information Update: 30 Dec 2014
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 Jul 2014 New trial record